FINALLOT

FINALLOT

Share this post

FINALLOT
FINALLOT
AstraZeneca's $800M Icosavax Acquisition; Biotech IPOs Reopening in 2024
Biotech

AstraZeneca's $800M Icosavax Acquisition…

Dec 19, 2023

Share this post

FINALLOT
FINALLOT
AstraZeneca's $800M Icosavax Acquisition; Biotech IPOs Reopening in 2024

BMS's $810M SystImmune Deal

Read →
Comments
User's avatar
© 2025 FINALLOT
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share